Dr. Alexis Kalergis
"Human Metapneumovirus causes high morbidity in the population, especially in infants and the elderly." The severity of this virus is the second cause of childhood pneumonia. Our team has developed a safe and effective vaccine against this virus. This has shown excellent protection results in pre-clinical studies.We are currently carrying out the clinical studies necessary to bring this vaccine onto the market and reduce the impact of this disease in the Chilean and international population."
Research Line / Vaccines
Project:
Safe and effective vaccines against Human Metapneumovirus (hMPV)
See more